RecruitingPhase 3NCT07794579
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Sponsor: Eli Lilly and Company
West Des Moines, IA · +79 more sites
4 recruiting obesity studies with a site in West Des Moines, IA.
Sponsor: Eli Lilly and Company
West Des Moines, IA · +79 more sites
Sponsor: Eli Lilly and Company
West Des Moines, IA · +49 more sites
Sponsor: Novo Nordisk A/S
West Des Moines, IA · +98 more sites
Sponsor: Eli Lilly and Company
West Des Moines, IA · +40 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.